Author

Greet Meulders

Institution: Janssen (Belgium)

Observed institutions: Johnson & Johnson (United States), Janssen (Belgium)

OpenAlex ID: A5059386339

Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor

2010 · Theo Dinklo, Hamdy Shaban, et al. · Journal of Pharmacology and Experimental Therapeutics · 78

Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice

2021 · Jonathan Janssens, Bart Hermans, et al. · Neurobiology of Disease · 17

P2‐045: Effect of Bace Inhibitor Treatment on Full‐Length and N‐Truncated AB Species in Cellular and Canine Models

2016 · Bianca Van Broeck, Ana Cascalho, et al. · Alzheimer s & Dementia

P4‐216: COMPARISON OF PLASMA Aβ ASSAYS AS PHARMACODYNAMIC READ‐OUT FOR BACE1 INHIBITOR TREATMENT IN CANINES

2014 · Bianca Van Broeck, Greet Meulders, et al. · Alzheimer s & Dementia

Works count: 4

Citation count: 95

H-index: 2

I10-index: 2